$COYA 4 SEC Filings

Filed On	Filing
09 Apr 2026	Form 4: Pavao Mark H, Director Granted 10,000 Stock Option (right to buy)
26 Jan 2026	Form 4: Snyder David S, Chief Financial Officer Granted 140,041 Stock Option (right to buy)
26 Jan 2026	Form 4: Grossman Fred, Chief Medical Officer Granted 140,041 Stock Option (right to buy)
26 Jan 2026	Form 4: Berman Howard, Director Granted 15,257 Stock Option (right to buy)
26 Jan 2026	Form 4: Swaminathan Arun, Director Granted 293,983 Stock Option (right to buy)
06 Jan 2026	Form 4: Villalobos Anabella, Director Granted 10,000 Stock Option (right to buy)
06 Jan 2026	Form 4: Goldstein Dov A Md, Director Granted 10,000 Stock Option (right to buy)
06 Jan 2026	Form 4: Weinand Dieter, Director Granted 10,000 Stock Option (right to buy)
06 Jan 2026	Form 4: Ross Wilbur L Jr, Director Granted 10,000 Stock Option (right to buy)
06 Jan 2026	Form 4: Lee Ann, Director Granted 10,000 Stock Option (right to buy)
19 Aug 2025	Form 4: Goldstein Dov A Md, Director Received 17,557 shares by exercise or conversion ($19.1K)
25 Feb 2025	Form 4: Lee Ann, Director Granted 5,000 Stock Option (right to buy)
25 Feb 2025	Form 4: Villalobos Anabella, Director Granted 5,000 Stock Option (right to buy)
25 Feb 2025	Form 4: Goldstein Dov A Md, Director Granted 5,000 Stock Option (right to buy)
25 Feb 2025	Form 4: Weinand Dieter, Director Granted 5,000 Stock Option (right to buy)
25 Feb 2025	Form 4: Ross Wilbur L Jr, Director Granted 5,000 Stock Option (right to buy)
13 Jan 2025	Form 4: Snyder David S, Chief Financial Officer Granted 140,562 Stock Option (right to buy)
13 Jan 2025	Form 4: Swaminathan Arun, Director Granted 240,964 Stock Option (right to buy)
13 Jan 2025	Form 4: Grossman Fred, Chief Medical Officer Granted 140,562 Stock Option (right to buy)
13 Jan 2025	Form 4: Berman Howard, Director Granted 150,602 Stock Option (right to buy)

Comments